6-Hydroxymelatonin protects against quinolinic-acid-induced oxidative neurotoxicity in the rat hippocampus

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 7, 2005, Pages 877-881

  Maharaj, D S ^a   Maharaj, H ^a   Antunes, E M ^a   Maree, D M ^a   Nyokong, T ^a   Glass, B D ^b   Daya, S ^a  

^a RHODES UNIVERSITY   (South Africa)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYMELATONIN; MELATONIN; PHTHALOCYANINE ZINC; QUINOLINIC ACID; SCAVENGER; SINGLET OXYGEN; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; QUANTUM YIELD; RAT;

ANIMALS; CARDIOTONIC AGENTS; FREE RADICAL SCAVENGERS; HIPPOCAMPUS; MALE; MELATONIN; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; QUINOLINIC ACID; RATS; RATS, WISTAR;

EID: 21044436893     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357056424     Document Type: Article

References (37)

1. Anoopkumar-Dukie, S., Walker, R. B., Daya, S. (2001) A sensitive and reliable method for the detection of lipid peroxidation in biological tissues. J. Pharm. Pharmacol. 53: 263-266
2. Bautista, A. P., Spitzer, J. J. (1990) Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin. Am. J. Physiol. 259: G907-G912
3. Bonilla, E. Tanji, K. Hirano, M. Vu, T. H. DiiMauro, S. Schon, E. A. (1999) Mitochondrial involvement in Alzheimer's disease. Biochim. Biophys. Acta 1410: 171-182
4. Cabrera, J., Reiter, R. J., Tan, D.-X., Qi, W., Sainz, R. M., Mayo, J. C., Garcia, J. J., Kim, S. J., El-Sokkary, G. (2000) Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings. Neuropharmacology 39: 507-514
5. Cagnoli, C. M., Atabay, C., Kharlamova, E., Manev, H. (1995) Melatonin protects neurons from singlet oxygen-induced apoptosis. J. Pineal Res. 18: 222-226
6. Costa, E. J. X., Lopez, R. H., Lamy-Freund, M. T. (1995) Permeability of pure lipid bilayers to melatonin. J. Pineal Res. 19: 123-126
7. Dawson, W. R., Windsor, M. W. (1968) Fluorescence yields of aromatic compounds. J. Phys. Chem. 72: 3251-3260
8. Gilad, E., Cuzzocrea, S., Zingarelli, B., Salzman, A. L., Szabo, C. (1997) Melatonin is a scavenger of peroxynitrite. Life Sci. 60: PL169-PL174
9. Heron, P., Daya, S. (2001) 17Beta-estradiol attenuates quinolinic acid insult in the rat hippocampus. Metab. Brain. Dis. 16: 187-198
10. König, J. F. R., Klippel, R. A. (1963) The rat brain. Williams & Wilkins, Baltimore, MD, pp 108-114
11. Lekieffre, D., Plotkine, M., Allix, M., Boulu, R. G. (1990) Kynurenic acid antagonises hippocampal quinolinic acid neurotoxicity: behavioural and histological evaluations. Neurosci. Lett. 4: 1264-1270
12. Lowry, O. H., Rosenbrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-267
13. Maharaj, D. S., Anoopkumar-Dukie, S., Glass, B. D., Antunes, E. M., Lack, B., Walker, R. B., Daya, S. (2002) The identification of the UV degradants of melatonin and their ability to scavenge free radicals. J. Pineal Res. 32: 257-261
14. Maharaj, D. S., Limson, J. L., Daya, S. (2003) 6-Hydroxymelatonin converts iron (III) to iron (II) and reduces iron-induced lipid peroxidation. Life Sci. 72: 1367-1375
15. Maree, S. (2002) Effects of axial ligands on the photosensitizing properties of silicon octaphenoxyphthalocyanine. PhD thesis, Rhodes University, pp 78-84, 92-93, 109
16. Matuszak, K., Reszka, K. J., Chignell, C. F. (1997) Reaction of melatonin and related indoles with hydroxyl radicals: EPR and SPIN trapping investigations. Free Radic. Biol. Med. 23: 367-372
17. Ottino, P., Duncan, J. R. (1997) Effect of α-tocopherol succinate on free radical and lipid peroxidaiton levels in BL6 melanoma cells. Free Radic. Biol. Med. 22: 1145-1151
18. Pierrefiche, G., Topall, G., Courboin, G., Henriet, I., Laborit, H. (1993) Antioxidant activity of melatonin in mice. Res. Commun. Chem. Pathol. Pharmacol. 80: 211-223
19. Reiter, R. J. (1993) The melatonin rhythm. Both a clock and calendar. Experientia 49: 654-664
20. Reiter, R. J. (1995) Oxidative processes and antioxidant defense mechanisms in the ageing brain. FASEB. J. 9: 526-533
21. Reiter R. J. (1998a) Antioxidant actions of melatonin. Adv. Pharmacol. 38: 103-116
22. Reiter, R. J. (1998b) Oxidative damage in the central nervous system. Protection by melatonin. Prog. Neurobiol. 56: 359-384
23. Reiter, R. J., Garcia, J. J., Pie, J. (1998) Oxidative toxicity in models of neurodegeneration: responses to melatonin. Restorative Neurol. Neurosci. 12: 135-142
24. Reiter, R. J., Tan, D. X., Qi, W. B., Manchester, L. C., Karbownik, M., Calvo, J. R. (2000) Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol. Signals Recept. 9: 160-171
25. Rios, C., Santamaria, A. (1991) Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem. Res. 16: 1139-1143
26. Schwarcz, R., Koler, C. (1983) Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci. Lett. 38: 85-90
27. Shida, C. S., Castrucci, A. M. L., Lamy-Freund, M. T. (1994) High melatonin solubility in aqueous medium. J. Pineal Res. 16: 198-201
28. Shuter, S. L., Davies, M. J., Garlick, P. B., Hearse, D. J., Slater, T. F. (1990) Studies on the effects of antioxidants and inhibitors of radical generation on free radical production in the reperfused rat heart using electron spin resonance spectroscopy. Free Radic. Res. Commun. 9: 223-232
29. Stone, T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45: 309
30. Tan, D. X., Manchester, L. C., Reiter, R. J., Plummer, B. F., Hardies, L. J., Weintraub, S. T., Vijayalaxmi, Shepard, A. M. (1998) A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys. Res. Commun. 253: 614-620
31. Tan, D. X., Manchester, L. C., Burkhardt, S., Sainz, R. M., Mayo, J. C., Kohen, R., Shohami, E., Huo, Y. S., Hardeland, R., Reiter, R. J. (2001) N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 15: 2294-2296
32. Tse, S. Y., Mak, I. T., Dickens, B. F. (1991) Antioxidative properties of harmane and β-carbolines alkaloids. Biochem. Pharmacol. 42: 459-464
33. Wolfensberger, M., Amsler, U., Cuenod, M., Foster, A. C., Whetsell, W. O., Schwarcz, R. (1983) Identification of quinolinic acid in rat and human brain tissue. Neurosci. Lett. 41: 247-252
34. Wu, H. Q., Baran, H., Ungerstedt, U., Schwarcz, R. (1992) Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo. Eur. J. Neurosci. 4: 1264-1270
35. Yoshida, M., Fukuda, A., Hara, M., Terada, A., Kitanaka, Y., Owada, S. (2003) Melatonin prevents the increase in hydroxyl radical-spin trap adduct formation caused by the addition of cisplatin in vitro. Life Sci. 72: 1773-1780
36. Yoshikawa, Y., Takano, H., Takahashi, S., Ichikawa, H., Kondo, M. (1994) Changes in tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure. Circulatory Shock 42: 53-58
37. Zar, J. H. (1974) Biostatistical analysis. Engelwood Cliffs, NJ: Prentice Hall, pp 151-466